Inhalable metal–organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy-Reference-Cited by-同舟云学术

Inhalable metal–organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy

Published:2024-05 Issue:5 Volume:14 Page:2281-2297
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Yan Chongzheng,Liu Ying^ORCID,Zhao Guozhi,Yang Huatian,Lv Huaiyou,Li Genju,Li Yuhan,Fu Yaqing,Sun Fengqin,Feng Yafei,Li Yizhe,Zhao Zhongxi

Publisher

Elsevier BV

Reference48 articles.

1. Non-small-cell lung cancer in 2022: a review for general practitioners in oncology;Mithoowani;Curr Oncol,2022

2. Zinc oxide nanoparticles inhibit osteosarcoma metastasis by downregulating beta-catenin via HIF-1α/BNIP3/LC3B-mediated mitophagy pathway;He;Bioact Mater,2022

3. New lung-cancer drugs extend survival times;Eisenstein;Nature,2020

4. Toward personalized treatment approaches for non-small-cell lung cancer;Wang;Nat Med,2021

5. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC;Chang;Lung Cancer,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application and prospect of Cu-based metal-organic frameworks in tumor therapy;Journal of Molecular Structure;2025-02

2. Revolutionizing Lung Cancer Treatment with Smart Pulmonary Drug Delivery Nanosystems;Journal of Drug Delivery Science and Technology;2024-09

3. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-08-16

4. Self-Boosting Cuproptosis-Based Synergistic Antitumor Therapy by GSH-Enhanced Cocatalysis and Copper Efflux Inhibition;ACS Applied Nano Materials;2024-08-09

5. Cuproptosis in cancer: biological implications and therapeutic opportunities;Cellular & Molecular Biology Letters;2024-06-25